Advertisement
Screener

Immunome, Inc. (IMNM) Lessee, Operating Lease, Liability, to be Paid, Year One

2.3 / 5 stars · 20/44 Roast Me

Immunome, Inc. Lessee, Operating Lease, Liability, to be Paid, Year One

Immunome, Inc. (IMNM) had Lessee, Operating Lease, Liability, to be Paid, Year One of $2.66 million as of 2026-06-30, per its 10-Q filed 2026-08-11.

Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-08-11

  • 2026-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $2.66M.
  • 2026-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $2.33M.
  • 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $1.47M.
  • 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $1.47M.
Period endLessee, Operating Lease, Liability, to be Paid, Year One
2026-06-30$2.66M
10-Q · filed 2026-08-11
2026-03-31$2.33M
10-Q · filed 2026-05-12
2025-12-31$1.47M
10-K · filed 2026-03-03
2025-09-30$1.47M
10-Q · filed 2025-11-06
2025-06-30$1.47M
10-Q · filed 2025-08-06
2025-03-31$1.30M
10-Q · filed 2025-05-12
2024-12-31$929.00K
10-K · filed 2025-03-19
2024-09-30$881.00K
10-Q · filed 2024-11-13
2024-06-30$879.00K
10-Q · filed 2024-08-12
2021-12-31$257.00K
10-K · filed 2022-03-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
Disc Medicine, Inc. (IRON)United States$2.553B-11.40
SUPERNUS PHARMACEUTICALS, INC. (SUPN)United States$2.517B-24.63
Nurix Therapeutics, Inc. (NRIX)United States$2.457B-5.39
SELLAS Life Sciences Group, Inc. (SLS)United States$2.420B-91.87
uniQure N.V. (QURE)$2.416B-4.93
MBX Biosciences, Inc. (MBX)United States$2.664B-25.36
Vera Therapeutics, Inc. (VERA)United States$2.402B-7.67
Harmony Biosciences Holdings, Inc. (HRMY)United States$2.399B11.67
NewAmsterdam Pharma Co N.V. (NAMS)$2.719B-15.37
Mineralys Therapeutics, Inc. (MLYS)United States$2.353B-6.82